Skip to main content
NIH funding notice RFA-DA-15-005

Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01)

Closed on July 31, 2014.

Posted
February 4, 2014
Close date
July 31, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $751,490 in first-year total cost, median $375,745.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 NXR-B (11)]2

Most frequent institutions

  1. BETH ISRAEL DEACONESS MEDICAL CENTER1
  2. UNIVERSITY OF MIAMI SCHOOL OF MEDICINE1
Competing awards under RFA-DA-15-005 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2015Role of the BBB in HIV brain infection during methamphetamine abuse1R01DA039576-01TOBOREK, MICHALUNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL$383,750ZDA1
2015Novel Mechanisms of Disarming Anti-HIV Host Defenses by Methamphetamine1R01DA039566-01GROOPMAN, JEROME EBETH ISRAEL DEACONESS MEDICAL CENTER, MA$367,740ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.